ProCE Banner Activity

CE / CME

GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM

Video

GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM will inform clinicians about the pleiotropic effects of GLP-1 RAs, the demonstrated clinical efficacy of these agents for managing patients with T2DM and a variety of comorbid conditions, and guideline recommendations for incorporating GLP-1 RAs into management strategies for T2DM.

AGENDA
Welcome and Introduction
GLP-1 RAs Have Multiple Physiologic Effects
GLP-1 RAs for a Variety of Medical Conditions
The Role of GLP-1 RAs in Managing T2DM: Evidence-based Recommendations
Question & Answer 

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit™

Nurse Practitioners: 1.00 AANP contact hour

Physicians: Maximum of 1.00 Medical Knowledge MOC point

Physicians: Maximum of 1.00 prescribed AAFP Credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: August 30, 2022

Expiration: August 30, 2023

No longer available for credit.

Share

Faculty

Lucia M. Novak

Lucia M. Novak, MSN, ANP-BC, BC-ADM

President, Diabesity, LLC
North Bethesda, Maryland
Co-Executive Director
Capital Health and Metabolic Center
Capital Diabetes and Endocrine Associates, LLC
Camp Springs and Silver Spring, Maryland

Jay H. Shubrook

Jay H. Shubrook, DO, FACOFP, FAAFP

Professor
Department of Clinical Sciences and Community Health
Diabetologist
Touro University California
College of Osteopathic Medicine
Vallejo, California

John White

John White, Jr., PA-C, PharmD

Chair and R. Keith Campbell Distinguished Professor in Diabetes Care
Department of Pharmacotherapy
Washington State University College of Pharmacy and Pharmaceutical Sciences
Pullman, WA

Eugene Wright

Eugene Wright, MD

Medical Director for Performance Improvement
South Piedmont Ares Health Education Center (AHEC)
Charlotte, NC
Consulting Associate 
Department of Medicine
Duke University Medical Center
Durham, NC

Provided by


Jointly provided by the Potomac Center for Medical Education and Rockpointe

ProCE Banner
ProCE Banner

Supporters

This activity is supported by an educational grant from Novo Nordisk.

Novo Nordisk

Target Audience

The intended audience for this educational initiative is primary care providers, including internal medicine and family medicine physicians, nurse practitioners, and physician assistants, who are front-line clinicians in managing patients with type 2 diabetes.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the pleiotropic mechanism of action of GLP-1 receptor agonists.

  • Discuss efficacy and safety data for approved GLP-1 receptor agonists, including efficacy for glycemic and extra-glycemic effects.

  • Incorporate GLP-1 receptor agonists into evidence-based individualized management plans for patients with type 2 diabetes aligned with current guideline recommendations.

Disclosure

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other relevant professional organizations, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of an accredited continuing education program provided by the Potomac Center for Medical Education are required to disclose to PCME all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by PCME in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by PCME to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by PCME.

Faculty, Authors, and Content Developers
The faculty, authors and content developers reported the following relevant financial relationships with ineligible companies:


Primary Author

Lucia M. Novak, MSN, ANP-BC, BC-ADM

President, Diabesity, LLC
North Bethesda, Maryland
Co-Executive Director
Capital Health and Metabolic Center
Capital Diabetes and Endocrine Associates, LLC
Camp Springs and Silver Spring, Maryland

Lucia M. Novak, MSN, ANP-BC, BC-ADM: Consulting Fee: Abbott Diabetes Care, Novo Nordisk, Provention Bio, Xeris; Speaker's Bureau: Abbott Diabetes Care, BI/Lilly, Novo Nordisk, Xeris.

Jay H. Shubrook, DO, FACOFP, FAAFP

Professor
Department of Clinical Sciences and Community Health
Diabetologist
Touro University California
College of Osteopathic Medicine
Vallejo, California

Jay H. Shubrook, DO, FACOFP, FAAFP: Consulting Fee: Abbott, Astra Zeneca, Bayer, Eli Lilly, Nevro, Novo Nordisk

John White, Jr., PA-C, PharmD

Chair and R. Keith Campbell Distinguished Professor in Diabetes Care
Department of Pharmacotherapy
Washington State University College of Pharmacy and Pharmaceutical Sciences
Pullman, WA

John R. White, Jr., PA-C, PharmD: Consulting Fee: Novo Nordisk; Stock Shareholder: Emishere Technologies

Eugene Wright, MD

Medical Director for Performance Improvement
South Piedmont Ares Health Education Center (AHEC)
Charlotte, NC
Consulting Associate 
Department of Medicine
Duke University Medical Center
Durham, NC

Eugene Wright, MD: Consulting Fee: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Lilly, Medtronic, Sanofi; Honoraria: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Lilly, Medtronic, Sanofi; Speakers' Bureau: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Lilly, Sanofi

Brian W. Jack, MD: has no relevant financial relationships.

Planners and Managers
The planners and managers reported the following relevant financial relationships with ineligible companies:  

Terry A. Glauser, MD, MPH: has no relevant financial relationships

Content Reviewers
The content reviewers reported the following financial relationships with ineligible companies:

Katie Propst, PhD: has no relevant financial relationships

FDA DISCLOSURE
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Instructions for Credit

There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Accreditation

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation Statement
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit or the evaluation, please email contact@potomacme.org

ABIM MOC Designation Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To recieve CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

AAFP Credit Designation Statement
The AAFP has reviewed GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM- Enduring and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 08/30/2022 to 08/30/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Association of Nurse Practitioners (AANP) Credit Designation Statement
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 1.0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22065626. This activity was planned in accordance with AANP Accreditation Standards and Policies.

American Academy of Physician Assistants (AAPA) Credit Designation Statement

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 8/30/2022 to 8/30/2023. AAPA reference number: CME-207846.

ABMS MOC Approval Statement
Through the American Board of Medical Specialties ("ABMS") ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

ABMS Lifelong Learning CME Activity
Family Medicine
Preventive Medicine